Molecular inconsistencies in a fragile X male with early onset ataxia

Loading...
Thumbnail Image
Citations
Web of Science:
Scopus:
Altmetric:
Altmetric::
Associated Records
File Licence
Editors
Date
2016-09-21
Source Title
Genes
Journal Title
Journal ISSN
Volume Title
Publisher
MDPI AG
Affiliation
Melbourne School of Psychological Sciences
Paediatrics (RCH)
Document Type
Journal Article
Subject Code
Citation
Hwang, Y. T., Dudding, T., Aliaga, S. M., Arpone, M., Francis, D., Li, X., Slater, H. R., Rogers, C., Bretherton, L., du Sart, D., Heard, R. & Godler, D. E. (2016). Molecular inconsistencies in a fragile X male with early onset ataxia. Genes, 7 (9), https://doi.org/10.3390/genes7090068.
Access Status
Open Access
Access URL
Open Access URL
Linked Resource URL
NHMRC Grant Code
ARC Grant Code
Description
Abstract
Mosaicism for FMR1 premutation (PM: 55-199 CGG)/full mutation (FM: >200 CGG) alleles or the presence of unmethylated FM (UFM) have been associated with a less severe fragile X syndrome (FXS) phenotype and fragile X associated tremor/ataxia syndrome (FXTAS)-a late onset neurodegenerative disorder. We describe a 38 year old male carrying a 100% methylated FM detected with Southern blot (SB), which is consistent with complete silencing of FMR1 and a diagnosis of fragile X syndrome. However, his formal cognitive scores were not at the most severe end of the FXS phenotype and he displayed tremor and ataxic gait. With the association of UFM with FXTAS, we speculated that his ataxia might be related to an undetected proportion of UFM alleles. Such UFM alleles were confirmed by more sensitive PCR based methylation testing showing FM methylation between 60% and 70% in blood, buccal, and saliva samples and real-time PCR analysis showing incomplete silencing of FMR1. While he did not meet diagnostic criteria for FXTAS based on MRI findings, the underlying cause of his ataxia may be related to UFM alleles not detected by SB, and follow-up clinical and molecular assessment are justified if his symptoms worsen.
Notes
Terms of Use
Keywords
Publisher Licence